Neurogene NGNE
NASDAQ NGNE
$24.85 -1.23 (-4.73%)
As of: Oct 22, 2026 · 12:14 PM EDT

Neurogene (NGNE) Net Margin (2015 - 2024)

Updated

Neurogene (NGNE) posted Net Margin of -8123.68% for FY2024.

Analysis

Neurogene (NGNE) Net Margin (2015 - 2024) Analysis & Trends

  • Annual Net Margin shows a five-year change of -8116.73 percentage points (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual Net Margin since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn 21.86%
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn 21.27%
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn 22.65%
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn 16.30%
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn 23.62%
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn -134.51%
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -1.65%
10 Neurogene 560.36 Mn -442.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,999.14%
Mar 31, 2023 -1,297.67%
Dec 31, 2022 -1,358.82%
Sep 30, 2022 -2,338.46%
Jun 30, 2022 -8,086.60%
Mar 31, 2022 -118,084.62%
Dec 31, 2021 -303,340.00%
Sep 30, 2021 -257,433.33%
Sep 30, 2019 -5.91%
Jun 30, 2018 11.67%
Sep 30, 2016 -5,736.62%
Jun 30, 2016 -8,516.41%
Mar 31, 2016 -5,546.28%
Sep 30, 2015 -55,944.44%
Jun 30, 2015 -39,583.33%
Mar 31, 2015 -42,746.67%
API Access

Neurogene Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NGNE&period=max&api_key=YOUR_API_KEY